EN DE

UBERDOC Health Technologies Corp (ESVNF) Fair Value & Analysis

Healthcare · US · Market cap $267K

UH UBERDOC Health Technologies Corp logo UBERDOC Health Technologies Corp ESVNF · US
Price$0.0410
Fair Value$0.1144
Upside+179.0%
Quality50/100
Watch UBERDOC Health Technologies Corp for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 0.0% net margin
negative free cash flow
Trails peers (2/8)
Narrow moat 10/100
Evidence: Low Range $0.0816 – $0.1349 Share as image

Fair value as of: Jul 29, 2026

From 1 valuation models · updated 12 days ago

A solid business, screening 179% undervalued on our models.

What matters now

  • The price is below even our cautious bear case ($0.0816). The market is more pessimistic than our downside scenario.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$12.10 $0.0010 Fair Value $0.1144 Apr 2021 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 29, 2026.

How to read this chart

60‑month range $0.0010 – $12.10 · fair‑value band $0.0816 – $0.1349 · the $0.0410 price screens below the $0.1144 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 29, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

UBERDOC Health Technologies Corp (ESVNF) currently trades at $0.0410, while our model-based Fair Value estimate is $0.1144, implying the stock looks roughly 179.0% undervalued today. The Quality Score stands at 50/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

It earns a return on equity of -15.4%. The balance sheet holds a net cash position of $1.7M. Fundamentals as of Jul 29, 2026

Our scenario range runs from $0.0816 (bear case) to $0.1349 (bull case); at $0.0410, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at 179%, ESVNF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $0.1400 $0.1800 $0.2800 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.1400 $0.1800 $0.2800 50

Notify me when ESVNF reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Return on equity -15.4%
Free cash flow −$665K FY2025
EPS (TTM) $-0.0100
Net cash $1.7M FY2025

Figures from reported company fundamentals · as of Jul 29, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 48 · Market factors (momentum, volatility) 7

Profitability 0
Margins and returns on capital today
Quality Growth 52
Are margins and returns improving?
Cashflow 14
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 94
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 15
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

UBERDOC Health Technologies Corp. operates a digital healthcare platform in global markets. It offers services that connect patients directly with medical specialists for in-person or virtual consultations, featuring transparent pricing and online booking without the need for insurance or referrals.

Full company description

UBERDOC Health Technologies Corp. operates a digital healthcare platform in global markets. It offers services that connect patients directly with medical specialists for in-person or virtual consultations, featuring transparent pricing and online booking without the need for insurance or referrals. The company provides access to specialties, such as Cardiology, Dermatology, Orthopedics, and Mental Health, and serves individual patients as well as employers seeking employee health benefits. The company is based in Vancouver, Canada.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

UBERDOC Health Technologies Corp reported revenue of $46.6K in FY2025 versus $0 in FY2021. Reported net income was −$598K in FY2025.

Growth Quality 0/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$46.6K
Latest YoY
−2.5%
Revenue
FY21 $0
FY22 $0
FY23 $0
FY24 $47.8K
FY25 $46.6K
Net income
FY21 −$2.6M
FY22 −$3.3M
FY23 −$5.5M
FY24 −$12.4M
FY25 −$598K

Watch ESVNF: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "UBERDOC Health Technologies Corp Fair Value". https://www.fairvalue-calculator.com/stock/ESVNF

Peer Group

Health Information Services · 126 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside +168% · Top 25%
Return on assets -17% · Bottom 25%
Net margin (TTM) 0% · Below median
Operating margin (TTM) 0% · Below median
Revenue growth 0% · Below median

Valuation Multiples vs Health Information Services median · lower = cheaper

P/B 0.15× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 0 · sector 33
PAST 0 · sector 8
HEALTH 0 · sector 98
DIVIDEND 0 · sector 35

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 29, 2026).

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $190.12 $95.12 -50%
Pro Medicus Limited PME A$194.84 A$23.74 -88%
BrightSpring Health Services, Inc BTSG $68.16 $21.31 -69%
HealthEquity, Inc HQY $97.67 $56.63 -42%
Hinge Health, Inc HNGE $88.80 $24.03 -73%
10x Genomics, Inc TXG $45.75 $17.18 -62%
Waystar Holding WAY $22.69 $12.86 -43%
Doximity, Inc DOCS $22.21 $17.18 -23%
Privia Health Group PRVA $28.10 $5.30 -81%
Inventurus Knowledge Solutions Limited IKS ₹1,846 ₹860.28 -53%

Compare UBERDOC Health Technologies Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is UBERDOC Health Technologies Corp (ESVNF) overvalued or undervalued?
As of Jul 29, 2026, our model estimates a fair value of $0.1144 versus a price of $0.0410, about +179% (undervalued).
What is the fair value of ESVNF?
Our model-based fair value for UBERDOC Health Technologies Corp is $0.1144 (as of Jul 29, 2026), built from audited fundamentals. The current price is $0.0410.
What is the quality score of ESVNF?
UBERDOC Health Technologies Corp has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of ESVNF?
The net profit margin of UBERDOC Health Technologies Corp is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track UBERDOC Health Technologies Corp and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.